REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 142 filers reported holding REVOLUTION MEDICINES INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $586,512 | +5.0% | 21,189 | +1.5% | 0.01% | 0.0% |
| Q2 2023 | $558,406 | +14.0% | 20,875 | -7.7% | 0.01% | +25.0% |
| Q1 2023 | $490,014 | +18.8% | 22,623 | +30.6% | 0.00% | 0.0% |
| Q4 2022 | $412,610 | +28.1% | 17,322 | +6.2% | 0.00% | +33.3% |
| Q3 2022 | $322,000 | +37.6% | 16,311 | +36.1% | 0.00% | +50.0% |
| Q2 2022 | $234,000 | -29.1% | 11,982 | -7.5% | 0.00% | -33.3% |
| Q1 2022 | $330,000 | +1.9% | 12,947 | +0.6% | 0.00% | +50.0% |
| Q4 2021 | $324,000 | -9.5% | 12,873 | -1.0% | 0.00% | -33.3% |
| Q3 2021 | $358,000 | -11.6% | 13,003 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $405,000 | +52.3% | 12,753 | +120.0% | 0.00% | +50.0% |
| Q1 2021 | $266,000 | +17.2% | 5,797 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $227,000 | – | 5,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |